"Cell Hypoxia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition of decreased oxygen content at the cellular level.
MeSH Number(s)
G03.495.278.300
G04.299.305.300
Concept/Terms
Cell Hypoxia- Cell Hypoxia
- Cell Hypoxias
- Hypoxia, Cell
- Hypoxias, Cell
- Hypoxia, Cellular
- Cellular Hypoxia
- Cellular Hypoxias
- Hypoxias, Cellular
- Anoxia, Cellular
- Anoxias, Cellular
- Cellular Anoxia
- Cellular Anoxias
- Cell Anoxia
- Anoxia, Cell
- Anoxias, Cell
- Cell Anoxias
Below are MeSH descriptors whose meaning is more general than "Cell Hypoxia".
Below are MeSH descriptors whose meaning is more specific than "Cell Hypoxia".
This graph shows the total number of publications written about "Cell Hypoxia" by people in Harvard Catalyst Profiles by year, and whether "Cell Hypoxia" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 4 | 4 | 8 |
| 1994 | 1 | 4 | 5 |
| 1995 | 2 | 12 | 14 |
| 1996 | 2 | 11 | 13 |
| 1997 | 3 | 11 | 14 |
| 1998 | 1 | 8 | 9 |
| 1999 | 3 | 7 | 10 |
| 2000 | 3 | 4 | 7 |
| 2001 | 3 | 9 | 12 |
| 2002 | 3 | 9 | 12 |
| 2003 | 5 | 10 | 15 |
| 2004 | 5 | 15 | 20 |
| 2005 | 3 | 12 | 15 |
| 2006 | 4 | 9 | 13 |
| 2007 | 2 | 9 | 11 |
| 2008 | 4 | 8 | 12 |
| 2009 | 2 | 17 | 19 |
| 2010 | 3 | 13 | 16 |
| 2011 | 3 | 20 | 23 |
| 2012 | 5 | 17 | 22 |
| 2013 | 6 | 22 | 28 |
| 2014 | 3 | 22 | 25 |
| 2015 | 3 | 20 | 23 |
| 2016 | 3 | 14 | 17 |
| 2017 | 3 | 18 | 21 |
| 2018 | 3 | 21 | 24 |
| 2019 | 6 | 20 | 26 |
| 2020 | 5 | 10 | 15 |
| 2021 | 4 | 10 | 14 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 3 | 3 |
Below are the most recent publications written about "Cell Hypoxia" by people in Profiles.
-
Lipoylation is dependent on the ferredoxin FDX1 and dispensable under hypoxia in human cells. J Biol Chem. 2023 09; 299(9):105075.
-
MYC overrides HIF-1a to regulate proliferating primary cell metabolism in hypoxia. Elife. 2023 07 10; 12.
-
Brain-Penetrating and Disease Site-Targeting Manganese Dioxide-Polymer-Lipid Hybrid Nanoparticles Remodel Microenvironment of Alzheimer's Disease by Regulating Multiple Pathological Pathways. Adv Sci (Weinh). 2023 04; 10(12):e2207238.
-
The optimal 18F-fluoromisonidazole PET threshold to define tumor hypoxia in preclinical squamous cell carcinomas using pO2 electron paramagnetic resonance imaging as reference truth. Eur J Nucl Med Mol Imaging. 2022 Oct; 49(12):4014-4024.
-
Fumarate is a terminal electron acceptor in the mammalian electron transport chain. Science. 2021 Dec 03; 374(6572):1227-1237.
-
Genetic Deletion of Vascular Endothelial Growth Factor Receptor 2 in Endothelial Cells Leads to Immediate Disruption of Tumor Vessels and Aggravation of Hypoxia. Am J Pathol. 2022 02; 192(2):379-388.
-
The 20S as a stand-alone proteasome in cells can degrade the ubiquitin tag. Nat Commun. 2021 10 26; 12(1):6173.
-
Neuroprotective effects of minocycline and KML29, a potent inhibitor of monoacylglycerol lipase, in an experimental stroke model: a small-animal positron emission tomography study. Theranostics. 2021; 11(19):9492-9502.
-
Genome-wide synthetic lethal screen unveils novel CAIX-NFS1/xCT axis as a targetable vulnerability in hypoxic solid tumors. Sci Adv. 2021 08; 7(35).
-
Anticoagulation therapy promotes the tumor immune-microenvironment and potentiates the efficacy of immunotherapy by alleviating hypoxia. J Immunother Cancer. 2021 08; 9(8).